Literature DB >> 8940759

Clear-cell carcinoma: an ultrastructural study of 57 tumors from various sites.

T J Kwon1, J Y Ro, B Mackay.   

Abstract

Clear-cell carcinoma is a convenient and frequently used descriptive term for a malignant epithelial neoplasm that is entirely or largely composed of cells with optically clear cytoplasm in hematoxylin-eosin-stained sections. Transmission electron microscopy was performed on 57 tumors from various sites to investigate the fine structural basis for the clarity of the cytoplasm. The clear appearance resulted from the presence of one or several of the following features, as the sole or predominant cause or in combination: glycogen, lipid droplets, mucin vacuoles or diffuse mucosubstances, dilated cisternae, swollen or unusually large mitochondria, large solitary membrane-limited vacuoles or numerous smaller vacuoles, intracytoplasmic lumens, expanded intercellular spaces, cytoplasmic pseudoinclusions, and a paucity of organelles. Degenerative changes contributed to the clear appearance by inducing swelling of mitochondria and creating lucent cytosol. The factors responsible for the clear cytoplasm were not always consistent with regard to tumor type or site of origin, but glycogen was the commonest reason among the 57 tumors studied and the principal cause in tumors of the female genital tract, skin, and salivary glands, while renal cell carcinomas tended to possess an admixture of glycogen and lipid droplets. Because of the heterogeneity of the subcellular changes that can produce optically clear cytoplasm, electron microscopy has a limited role in determining the primary site of a metastatic clear-cell carcinoma.

Entities:  

Mesh:

Year:  1996        PMID: 8940759     DOI: 10.3109/01913129609016356

Source DB:  PubMed          Journal:  Ultrastruct Pathol        ISSN: 0191-3123            Impact factor:   1.094


  6 in total

1.  Clear cell clusters in the kidney: a rare finding that should not be misdiagnosed as renal cell carcinoma.

Authors:  José-Antonio Ortiz-Rey; Carmen Fachal; Laura Juaneda-Magdalena; Mónica Muñoz-Martín; Alfredo Repáraz-Andrade; Susana Teijeira; José-María Lamas-Barreiro; Sheila Almuster-Domínguez; Pilar San Miguel-Fraile; Carolina Gómez-de María
Journal:  Virchows Arch       Date:  2021-01-14       Impact factor: 4.064

2.  Development of a membrane lipid metabolism-based signature to predict overall survival for personalized medicine in ccRCC patients.

Authors:  Maode Bao; Run Shi; Kai Zhang; Yanbo Zhao; Yanfang Wang; Xuanwen Bao
Journal:  EPMA J       Date:  2019-11-07       Impact factor: 6.543

3.  Obesity-Dependent Adipokine Chemerin Suppresses Fatty Acid Oxidation to Confer Ferroptosis Resistance.

Authors:  Sze Kiat Tan; Iqbal Mahmud; Flavia Fontanesi; Michelle Puchowicz; Chase K A Neumann; Anthony J Griswold; Rutulkumar Patel; Marco Dispagna; Hamzah H Ahmed; Mark L Gonzalgo; J Mark Brown; Timothy J Garrett; Scott M Welford
Journal:  Cancer Discov       Date:  2021-03-23       Impact factor: 39.397

4.  HIF drives lipid deposition and cancer in ccRCC via repression of fatty acid metabolism.

Authors:  Weinan Du; Luchang Zhang; Adina Brett-Morris; Brittany Aguila; Janos Kerner; Charles L Hoppel; Michelle Puchowicz; Dolors Serra; Laura Herrero; Brian I Rini; Steven Campbell; Scott M Welford
Journal:  Nat Commun       Date:  2017-11-24       Impact factor: 14.919

5.  Colon adenoma and adenocarcinoma with clear cell components - two case reports.

Authors:  Yuzo Oyama; Haruto Nishida; Takahiro Kusaba; Hiroko Kadowaki; Motoki Arakane; Kazuhisa Okamoto; Junpei Wada; Shogo Urabe; Tsutomu Daa
Journal:  Diagn Pathol       Date:  2019-05-10       Impact factor: 2.644

6.  Lobulated Bowen's Disease with a Clear Cell Change.

Authors:  Dong Yoon Lee; Ki Hwa Choi; Su Hyun Park; Ji Yeoun Lee; Tae Young Yoon
Journal:  Ann Dermatol       Date:  2017-06-21       Impact factor: 1.444

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.